Wainua (eplontersen)

pCPA File Number: 22906

Negotiation Status:

Concluded with an LOI

Indication(s):

Polyneuropathy in hereditary transthyretin-mediated amyloidosis

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0826-000

pCPA Engagement Letter Issued:

2025-02-18

Negotiation Process Concluded:

2025-05-07